Polyhomoarginine (PHA) Polymers And Uses Thereof
AssigneeSingapore Health Services Pte Ltd
InventorsRajamani LAKSHMINARAYANAN, Jodhbir Singh MEHTA, Tun Aung THET
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of polyhomoarginine comprising 6-26 homoarginine residues or a pharmaceutically acceptable salt thereof, in the treatment of an infection, wherein the infection is a fungal infection, a bacterial infection or a combination thereof. The present invention also relates to the use of polyhomoarginine comprising 6-26 homoarginine residues or a pharmaceutically acceptable salt thereof in a formulation or in a contact lens.
Claims14
1-20. (canceled)
A method of treating an infection, wherein the infection is a fungal infection, a bacterial infection or a combination thereof, comprising administering a polyhomoarginine comprising 6-26 homoarginine residues or a pharmaceutically acceptable salt thereof to a subject.
A contact lens comprising polyhomoarginine comprising 6-26 homoarginine residues or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.